Brief: Akeso FY Revenue RMB 3,056.3 Million
26/03/2026 15:40
March 26 (Reuters) - Akeso Inc 9926.HK: FY REVENUE RMB 3,056.3 MILLION FY LOSS ATTRIBUTABLE RMB1.11 BILLION Further company coverage: 9926.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akeso
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Akeso drops most in nearly three months on discounted share sale
Brief: Akeso To Place 20 Million New Shares At HK$97.76 Per Share
Factbox: Major drugmakers turn to China for licensing deals